Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

Colaboración

Año: 2025

Masini, S; Basa, MA; Calles, A; Cabellos, RA; Echebarria, ID; Puchol, CT; Kareaga, MM; Cabezon-Gutierrez, L; Perez, MCE; Lage, Y; Lorenzo, EG; Navarro, F; Sereno, M; Martínez, SF; García-Benito, C; Pinto, LM; Andrade, CA; Sequero, S; Martinez, JM; Lopez-Martín, A; Martínez, AA; Martín-Soberon, MC; Lucia-Gozalvez, C; Rubio, J; Tallafigo, L; Garrido, A; Peressini, M; Torres-Jimenez, J; Zurera, M; Bote, H; Ponce, S; Paz-Ares, L; Zugazagoitia, J; Baena, J

Título: CANCERS

• Q2